Michael Michael

Pelvic exenteration, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancy: experience and outcomes from an exenterative and peritonectomy unit

Michael P Flood, Peadar S Waters, Mikael Soucisse, Robert Ramsay, Michael Michael, Jacob J McCormick, Satish Warrier, Alexander Heriot

Journal article  |  2021  |  LANGENBECKS ARCHIVES OF SURGERY

PURPOSE: Pelvic exenteration (PE) for locally advanced pelvic malignancy is well established, though high rates of morbidity and m..

Evaluation of pharmacogenomics and hepatic nuclear imaging-related covariates by population pharmacokinetic models of irinotecan and its metabolites

Zheng Liu, Jennifer H Martin, Winston Liauw, Sue-Anne Mclachlan, Emma Link, Anetta Matera, Michael Thompson, Michael Jefford, Rod J Hicks, Carleen Cullinane, Athena Hatzimihalis, Ian Campbell, Simone Crowley, Phillip J Beale, Christos S Karapetis, Timothy Price, Mathew E Burge, Michael Michael

Journal article  |  2021  |  EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

BACKGROUND: Body surface area (BSA)-based dosing of irinotecan (IR) does not account for its pharmacokinetic (PK) and pharmacodyna..

The predictive value of PET/CT for distant recurrences in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy

Joseph C Kong, Jennifer Ryan, Timothy Akhurst, Samuel Y Ngan, Michael Michael, Jeanne Tie, Satish K Warrier, Alexander G Heriot

Journal article  |  2021  |  JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY

INTRODUCTION: It is well recognized that pathological complete response (pCR) for locally advanced rectal cancer after neoadjuvant..

Complete pathological response in rectal cancer utilising novel treatment strategies for neo-adjuvant therapy: A systematic review.

K Wilson, M Flood, V Narasimhan, T Pham, S Warrier, R Ramsay, M Michael, A Heriot

Journal article  |  2021  |  Eur J Surg Oncol

BACKGROUND: Locally advanced rectal cancer is routinely treated with neo-adjuvant long course chemoradiotherapy or short course ra..

A Randomized Phase 3 Trial of Palliative Radiation Therapy Versus Concurrent Chemotherapy and Palliative Radiation Therapy in Patients With Good Performance Status, Locally Advanced, or Metastatic Non-Small Cell Lung Cancer With Symptoms Due to Intrathoracic Disease Who Are Not Suitable for Radical Chemo- Radiation Therapy: Results of the Trans-Tasman Radiation Oncology Group 11.03 Trial

Margot Lehman, Anne Bernard, Adrienne See, Madeleine King, Michael Michael

Journal article  |  2021  |  PRACTICAL RADIATION ONCOLOGY

PURPOSE: We compared intrathoracic symptom response rate, quality of life (QOL) and toxicity in patients with non-small cell lung ..

Synchronous Liver Resection, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Liver and Peritoneal Metastases: A Systematic Review and Meta-analysis

Michael P Flood, Atandrila A Das, Mikael L Soucisse, Joseph Kong, Robert G Ramsay, Michael Michael, Benjamin PT Loveday, Satish K Warrier, Alexander G Heriot

Journal article  |  2021  |  DISEASES OF THE COLON & RECTUM

BACKGROUND: Synchronous liver resection, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy for colorectal liver..

Outcomes following synchronous liver resection, cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal liver and peritoneal metastases: A bi-institutional study

Michael P Flood, Peadar S Waters, Michael E Kelly, Conor Shields, John Conneely, Robert Ramsay, Michael Michael, Benjamin Loveday, Satish K Warrier, Jurgen Mulsow, Alexander G Heriot

Journal article  |  2021  |  SURGICAL ONCOLOGY-OXFORD

PURPOSE: Synchronous liver resection, cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for colore..

Efficacy and safety of 177Lu-DOTATATE in lung neuroendocrine tumors: a bi-center study.

Lamiaa Zidan, Amir Iravani, Kira Oleinikov, Simona Ben-Haim, David J Gross, Amichay Meirovitz, Ophra Maimon, Tim Akhurst, Michael Michael, Rodney J Hicks, Simona Grozinsky-Glasberg, Grace Kong

Journal article  |  2021  |  J Nucl Med

To assess the efficacy and safety of 177Lu-DOTATATE in patients with somatostatin receptor (SSR) positive lung neuroendocrine tumo..

Immune Checkpoint Blockade in Lower Gastrointestinal Cancers: A Systematic Review

KC Wilson, MP Flood, D Oh, N Calvin, M Michael, RG Ramsay, AG Heriot

Journal article  |  2021  |  ANNALS OF SURGICAL ONCOLOGY

BACKGROUND: Limited therapy options exist for patients with treatment-refractory metastatic colorectal or anal cancers, prompting ..

Chemotherapy at the end of life in colorectal and pancreatic cancer: Real-world data and trends over time.

Catherine Dunn, Belinda Lee, Jeremy David Shapiro, Rachel Wong, Grace Gard, Michael Michael, Wei Hong, Matthew E Burge, Vanessa Wong, Ben Thomson, Sumitra Ananda, Sue-Anne McLachlan, Brett Knowles, Mehdrad Nikfarjam, Jeanne Tie, Ross Jennens, Joseph James McKendrick, Margaret Lee, Suzanne Kosmider, Peter Gibbs

Conference Proceedings  |  2021  |  Journal of Clinical Oncology

e18723 Background: Chemotherapy at the end of life (CEOL) is widely accepted as an indicator of aggressive care. However, the evi..